Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GZR4 vs Insulin Degludec in Type 2 Diabetes
NCT06202079Phase 2Completed
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Aug 2023
- Primary completion
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of GZR4 in type 2 diabetes mellitus (T2DM), sponsored by Gan & Lee Pharmaceuticals. Started Aug 2023; status: completed.
02
Drugs
GZR4
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06202079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06202079.